Quotient Biodiagnostics is a commercial-stage in-vitro diagnostics company based in Newtown, PA. They are dedicated to developing cutting-edge solutions that accelerate and transform disease detection and diagnosis for patients and physicians. With a focus on growth and expansion in clinical diagnostics, their innovative products, such as Alba reagents for blood transfusion and the MosaiQ solution, aim to provide efficient screening, simplify diagnostic pathways, and deliver quick comprehensive diagnostic results, ultimately shortening time to diagnosis and treatment.
As autoimmune and allergy cases continue to rise globally, Quotient Biodiagnostics aims to meet the increasing demand for efficient screening and better lab workflows. Their MosaiQ solution not only simplifies specialty testing in clinical labs but also creates the possibility for simultaneous rapid testing on the same platform, offering clinical and economical value for customers. With a market-leading testing portfolio in autoimmunity and plans to expand into attractive adjacencies, Quotient Biodiagnostics is committed to providing innovative diagnostic solutions that improve patient outcomes and enhance the efficiency of healthcare providers worldwide.
Generated from the website